Skip to main content
. 2022 Sep;60(3):350–360. doi: 10.17113/ftb.60.03.22.7405

Fig. 4.

Fig. 4

Morphology of MDA-MB-231 cells after treatment with IC50 of capsanthin extract or capsanthin-loaded micelles of diosgenin polyethylene glycol succinate 1000 (cap-DPGS-1000): a−c) control and rhodamine staining images after treatment with capsanthin extract and cap-DPGS-1000, respectively, d−f) control and 2′,7′-dichlorofluorescein diacetate staining images after treatment with capsanthin extract and cap-DPGS-1000, respectively. Control=stained untreated MDA-MB-231 cells